In the United States alone, about 1 in 10 adults use these drugs regularly. Some well-known brands include Prilosec, Nexium, ...

Ardelyx's IBSRELA shows strong 57% sales growth, but faces stiff competition and uncertain sustainability. Click here to read ...

Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for ...

A clinical-stage biotech company based in Los Altos, California, developing treatments for kidney diseases.

Dr. Dustin T. Smith and Dr. Joanna M. Bonsall reviewed nine key updates in hospital medicine at SHM Converge 2025.

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Akebia Therapeutics, Inc. (NASDAQ:AKBA) is one of the. On June 4, the company published pre-specified analyses for its ...

FDA issues a complete response letter for oxylanthanum carbonate, a treatment for hyperphosphatemia in patients with chronic ...